TomoTherapy Incorporated and its subsidiaries develop, manufacture, market, and sell radiation therapy solutions to treat a range of cancer types. Its TomoTherapy treatment systems include the Hi Art treatment system, which delivers CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD treatment system that includes TomoHelical and TomoDirect treatment modalities to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile treatment system, which is a relocatable radiation therapy solution. The company markets and sells its products to hospitals and cancer treatment centers in North America, Europe, the Middle East, and the Asia-Pacific. It sells markets and sells its products through direct sales personnel, third-party distributors, and third-party sales agents or distributors. The company was founded in 1997 and is headquartered in Madison, Wisconsin.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.